| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
An Evidence-Based Guide to Cholesterol-Lowering Guidelines
|
Waters, David D.
|
|
2017
|
33 |
3 |
p. 343-349
7 p.
|
article
|
| 2 |
Barriers to the Implementation of Lipoprotein Apheresis in Canada
|
Filler, Guido
|
|
2017
|
33 |
3 |
p. 409-411
3 p.
|
article
|
| 3 |
Cardiovascular Risk Factor Management Performance in Canada and the United States: A Systematic Review
|
Alabousi, Mostafa
|
|
2017
|
33 |
3 |
p. 393-404
12 p.
|
article
|
| 4 |
Contemporary Trends in the Management and Outcomes of Patients With Familial Hypercholesterolemia in Canada: A Prospective Observational Study
|
Brunham, Liam R.
|
|
2017
|
33 |
3 |
p. 385-392
8 p.
|
article
|
| 5 |
Diabetes for Cardiologists: Practical Issues in Diagnosis and Management
|
Mancini, G.B. John
|
|
2017
|
33 |
3 |
p. 366-377
12 p.
|
article
|
| 6 |
Editorial Board
|
|
|
2017
|
33 |
3 |
p. A2-A3
nvt p.
|
article
|
| 7 |
Effective Management of Cardiovascular Risk Factors—Are We Doing Enough?
|
Teo, Koon K.
|
|
2017
|
33 |
3 |
p. 300-302
3 p.
|
article
|
| 8 |
Familial Hypercholesterolemia: Awareness, Appraisal, and Action
|
Genest, Jacques
|
|
2017
|
33 |
3 |
p. 298-299
2 p.
|
article
|
| 9 |
Genetics for the Identification of Lipid Targets Beyond PCSK9
|
Wang, Linda R.
|
|
2017
|
33 |
3 |
p. 334-342
9 p.
|
article
|
| 10 |
High-Density Lipoproteins: Biology, Epidemiology, and Clinical Management
|
Choi, Hong Y.
|
|
2017
|
33 |
3 |
p. 325-333
9 p.
|
article
|
| 11 |
Information for Readers
|
|
|
2017
|
33 |
3 |
p. A7-
1 p.
|
article
|
| 12 |
Macrophage Apoptosis and Necrotic Core Development in Atherosclerosis: A Rapidly Advancing Field with Clinical Relevance to Imaging and Therapy
|
Gonzalez, Leticia
|
|
2017
|
33 |
3 |
p. 303-312
10 p.
|
article
|
| 13 |
MicroRNAs in the Pathobiology and Therapy of Atherosclerosis
|
Laffont, Benoit
|
|
2017
|
33 |
3 |
p. 313-324
12 p.
|
article
|
| 14 |
New Drugs for Atherosclerosis
|
Bruikman, Caroline S.
|
|
2017
|
33 |
3 |
p. 350-357
8 p.
|
article
|
| 15 |
Optimal Low-Density Lipoprotein Cholesterol for Cardiovascular Prevention: How Low Should We Go?
|
Anderson, Todd J.
|
|
2017
|
33 |
3 |
p. 405-408
4 p.
|
article
|
| 16 |
Recent Temporal Changes in Atherosclerotic Cardiovascular Diseases in Ontario: Clinical and Health Systems Impact
|
Tu, Jack V.
|
|
2017
|
33 |
3 |
p. 378-384
7 p.
|
article
|
| 17 |
Table of Contents
|
|
|
2017
|
33 |
3 |
p. A5-A6
nvt p.
|
article
|
| 18 |
The Emerging Epidemic of Cardiovascular Risk Factors and Atherosclerotic Disease in Developing Countries
|
Teo, Koon K.
|
|
2017
|
33 |
3 |
p. 358-365
8 p.
|
article
|
| 19 |
The Rise and Fall of Tuberculosis and Atherosclerosis: First There Is a Mountain…
|
Waters, David D.
|
|
2017
|
33 |
3 |
p. 295-297
3 p.
|
article
|
| 20 |
Three-Dimensional and Conventional Carotid Ultrasound for Assessment of Carotid Plaque in a Stroke Patient: A Simple Way to Validate Findings
|
Kalashyan, Hayrapet
|
|
2017
|
33 |
3 |
p. 412.e1-412.e3
407881 p.
|
article
|
Journal description